Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

We recently compiled a list of the 13 Best Forever Stocks to Buy Right Now. In this article, we are going to take a look at ...

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...

The firm owned 12,436 shares of the company’s stock after selling 231 shares during the period. River Street Advisors LLC’s holdings in Johnson & Johnson were worth $1,798,000 as of its most ...

Johnson & Johnson introduces TECNIS PureSee IOL for presbyopia in India, offering high-quality vision and reduced visual ...

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy. However ...